Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Operating Grant

McGill University

$100,000.00

Can genetic polymorphisms explain the cardiovascular risk of nonsteroidal anti-inflammatory drugs?

EF 2008-09

Résumé
Anti-inflammatory drugs (NSAIDs) are widely used for fever, pain and inflammation. NSAIDs are the most common class of drug prescribed today and are associated with significant health benefits. However, recent studies have raised concerns and controversy about their cardiovascular risk. Cardiovascular and musculoskeletal diseases constitute major public health problems both in terms of quality of life and health expenditures. Since the frequency of both diseases increases sharply with age, it is important to assure that any cardiovascular risks associated with NSAIDs are well characterized and understood. This project aims to examine if an interaction between patient's genetic profile and NSAID drug exposure may explain an individual's risk for a heart attack. Clearly, providing this additional individual safety information and advancing our understanding of the biological mechanism by which these cardiovascular events are triggered are worthwhile goals.
Programme
Operating Grant
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
183805
Name
Brophy James M
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Clinical
Prcname2
Cardiovascular System - B: Heart and Circulation
Projecttitle
Can genetic polymorphisms explain the cardiovascular risk of nonsteroidal anti-inflammatory drugs?
Programtype2
Operating Grants
Orgnameinp2
McGill University
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Cardiovascular Safety; Gene*Drug Interaction; Genetic Polymorphisms; Genome Wide Association Studies; Nsaids; Pharmacogenomics
Abstract
Anti-inflammatory drugs (NSAIDs) are widely used for fever, pain and inflammation. NSAIDs are the most common class of drug prescribed today and are associated with significant health benefits. However, recent studies have raised concerns and controversy about their cardiovascular risk. Cardiovascular and musculoskeletal diseases constitute major public health problems both in terms of quality of life and health expenditures. Since the frequency of both diseases increases sharply with age, it is important to assure that any cardiovascular risks associated with NSAIDs are well characterized and understood. This project aims to examine if an interaction between patient's genetic profile and NSAID drug exposure may explain an individual's risk for a heart attack. Clearly, providing this additional individual safety information and advancing our understanding of the biological mechanism by which these cardiovascular events are triggered are worthwhile goals.
Competitiondate
200810
Approvedterm2
1 yr 0 mth
Pinamesdelim
Brophy, James M
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~